AXSM logo

AXSM
Axsome Therapeutics Inc

11,708
Mkt Cap
$7.47B
Volume
554,080.00
52W High
$152.94
52W Low
$75.56
PE Ratio
-31.70
AXSM Fundamentals
Price
$148.17
Prev Close
$148.75
Open
$148.67
50D MA
$137.18
Beta
0.78
Avg. Volume
599,854.42
EPS (Annual)
-$5.99
P/B
101.10
Rev/Employee
$564,704.25
Loading...
Loading...
News
all
press releases
TFG Asset Management GP Ltd Increases Position in Axsome Therapeutics, Inc. $AXSM
TFG Asset Management GP Ltd boosted its holdings in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) by 22.9% during the second quarter, according to its most recent disclosure with...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Axsome Therapeutics, Inc. $AXSM Position Lowered by Eventide Asset Management LLC
Eventide Asset Management LLC trimmed its position in Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) by 2.6% in the second quarter, according to its most recent disclosure with the SEC. The...
MarketBeat·2d ago
News Placeholder
Bellevue Group AG Decreases Stake in Axsome Therapeutics, Inc. $AXSM
Bellevue Group AG cut its stake in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) by 41.7% in the second quarter, according to the company in its most recent disclosure with the SEC...
MarketBeat·2d ago
News Placeholder
9,555 Shares in Axsome Therapeutics, Inc. $AXSM Purchased by WINTON GROUP Ltd
WINTON GROUP Ltd bought a new stake in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the...
MarketBeat·3d ago
News Placeholder
Hood River Capital Management LLC Acquires Shares of 371,104 Axsome Therapeutics, Inc. $AXSM
Hood River Capital Management LLC acquired a new position in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) in the 2nd quarter, according to its most recent disclosure with the SEC...
MarketBeat·7d ago
News Placeholder
Kennedy Capital Management LLC Boosts Holdings in Axsome Therapeutics, Inc. $AXSM
Kennedy Capital Management LLC boosted its holdings in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) by 380.2% in the second quarter, according to the company in its most recent 13F...
MarketBeat·8d ago
News Placeholder
Quantbot Technologies LP Grows Position in Axsome Therapeutics, Inc. $AXSM
Quantbot Technologies LP lifted its position in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) by 6,943.2% in the second quarter, according to its most recent 13F filing with the...
MarketBeat·8d ago
News Placeholder
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Receives Average Recommendation of "Moderate Buy" from Analysts
Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM - Get Free Report) have earned an average rating of "Moderate Buy" from the eighteen brokerages that are currently covering the firm, MarketBeat...
MarketBeat·9d ago
News Placeholder
Axsome Therapeutics (NASDAQ:AXSM) CEO Herriot Tabuteau Sells 20,163 Shares
Axsome Therapeutics, Inc. (NASDAQ:AXSM - Get Free Report) CEO Herriot Tabuteau sold 20,163 shares of the company's stock in a transaction on Wednesday, December 3rd. The shares were sold at an...
MarketBeat·9d ago
News Placeholder
Axsome Therapeutics (NASDAQ:AXSM) CEO Sells $7,121,346.68 in Stock
Axsome Therapeutics, Inc. (NASDAQ:AXSM - Get Free Report) CEO Herriot Tabuteau sold 49,252 shares of Axsome Therapeutics stock in a transaction dated Tuesday, December 2nd. The shares were sold at an...
MarketBeat·9d ago

Latest AXSM News

View

Advertisement|Remove ads.

Advertisement|Remove ads.